Idexx Laboratories — Q2 2023 Earnings Presentation

4 slides from Idexx Laboratories's earnings presentation, Aug 10, 2023

Slide 1: IDEXX Q2 2023 Earnings Highlights
IDEXX Q2 2023 Earnings Highlights (NASDAQ: IDXX) Operating Diluted Revenue Profit Earnings Per Share $944M $296M $2.67 Reported growth: +10% 31.4% of Revenue Reported growth: +71% Organic growth: +10% YoY change in basis points: CAG Diagnostics Recurring Reported +1,060 bps Comparable growth: +77% O
Slide 2: 2023 Growth and Financial Performance Outlook
IDEXX Q2 2023 Earnings Highlights (NASDAQ: IDXX) 2023 Growth and Financial Performance Outlook Commentary • Updates 2023 estimates to reflect solid first half results, consistent expectations for solid second half growth and updated foreign exchange rate impact estimates ◦ Increases revenue guidance
Slide 3: U.S. Companion Animal Practice Growth Update
U.S. Companion Animal Practice Growth Update As of June 30, 2023 Total Practice Revenue and Visit Growth Weighted Average Year-over-Year % Change Per Practice* 20% 17.5% 15% Practice Revenue 10% 10.8% 6.9% 5.4% 5.5% 5.6% 4.6% 4.3% 5% 3.8% 2.9% 0% Total Visits 1.2% 1.4% -1.0% -2.1% -5% -3.3%-3.3%-3.9
Slide 4: Contributors to U.S. Companion Animal Diagnostic Revenue Growth per Practice
U.S. Companion Animal Practice Growth Update As of June 30, 2023 Contributors to U.S. Companion Animal Diagnostic Revenue Growth per Practice** 16% 12% Q2’2023 8% + 9.0% + 8.5% Year-Over-Year 4% Growth (%) -1.0% + 0.5% 0% -4% 16% 12% 8% + 7.5% + 5.5% Q2’2022 4% - 3.0% 0% + 1.0% -4% 16% + 6.0% + 13.0